Treating Insomnia to Help Diabetes Care in Primary Clinics
Tests cognitive behavioral therapy for insomnia in adults with type 2 diabetes and poor sleep.
Key facts
- Who runs it
- Tulane University
- Where
- Zachary, United StatesSee the site
- Trial code
- Registry title
- Enhancing Diabetes Care by Treating Insomnia
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Cognitive Behavioral Therapy for Insomnia
- Usual care for diabetes management
- Usual care for treatment of insomnia
- Record updated
- 2 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 40 or older with type 2 diabetes that is not well controlled and with insomnia. It tests a 6-week talking therapy for insomnia.
- Age
- 40 years or older
- Sex
- All sexes can join
- Disease stage
- Type 2 diabetes with the most recent HbA1c above 7% (53 mmol/mol) within the past year, and an Insomnia Severity Index (ISI) score of 15 or higher
- Biomarker or test result
- HbA1c above 7% (53 mmol/mol); ISI score of 15 or higher
Main reasons for not taking part
- Diagnosed or self-reported sleep apnea
- Pregnant or planning to become pregnant during the study
- A psychiatric or medical condition that would interfere with study procedures
- Taking part in another diabetes clinical trial
- Living in the same household as another participant
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- aged 40 or older
- receive primary care from participating clinic
- diagnosis of type 2 diabetes
- most recent hemoglobin A1c (HbA1c) >7% within the past year
- Insomnia Severity Index (ISI) score ≥15
- able to speak English
Who cannot take part
- having a psychiatric or medical condition that would interfere with the ability to complete study procedures
- participating in another diabetes clinical trial
- diagnosed or self-reported sleep apnea
- pregnant or planning to become pregnant during the study period
- living in same household as another participant
- required to work night shifts
Where in United States
- Southeast Community Health SystemsZachary, United StatesContact: Erin Peacock, PhD, MPHTaking people
About the trial
What the trial wants to find out
Insomnia is highly prevalent in individuals with type 2 diabetes (T2D) and is associated with poor glycemic control. Louisiana has one of the highest diabetes prevalence rates in the U.S., with significant disparities by race, income, and rural residence. Despite growing recognition of sleep's role in diabetes management, sleep disturbances remain largely unaddressed in diabetes care. Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment for chronic insomnia, yet it is underutilized in primary care clinics such as federally qualified health centers (FQHCs) that serve high-risk populations.
Read full original descriptionShow less
The long-term goal of this research is to improve cardiometabolic health and reduce diabetes disparities by integrating sleep interventions into diabetes care. This pilot study aims to: (1) evaluate the impact of CBT-I on sleep and diabetes-related outcomes, and (2) assess the acceptability, feasibility, and fidelity of implementing a 6-week CBT-I program in an FQHC setting.
The investigators will conduct a randomized controlled trial (RCT) with 30 FQHC patients (aged 40+) with uncontrolled T2D (HbA1c >7%) and comorbid insomnia (Insomnia Severity Index (ISI) score ≥15). Participants will be randomly assigned to either the CBT-I intervention or usual care. Sleep (ISI scores, actigraphy) and cardiometabolic (HbA1c, fasting glucose, insulin) outcomes will be assessed at baseline and three months post-randomization. Implementation success will be evaluated using fidelity, feasibility, and acceptability measures. Findings will provide preliminary evidence for integrating CBT-I into primary care, informing larger trials to improve diabetes outcomes and reduce disparities in Louisiana.
The 2 groups in the trial
- Cognitive Behavioral Therapy for InsomniaTreatment being tested
Treatment: Cognitive Behavioral Therapy for Insomnia, Usual care for diabetes management, and Usual care for treatment of insomnia
- Usual CareExisting treatment, for comparison
Treatment: Usual care for diabetes management and Usual care for treatment of insomnia
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Enhancing Diabetes Care: Implementing Cognitive Behavioral Therapy for Insomnia to Improve Sleep and Cardiometabolic Outcomes
- Plain-language title
- Treating Insomnia to Help Diabetes Care in Primary ClinicsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 2 September 2026